A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/568 (2006.01)
Patent
CA 2697160
The invention relates to pharmaceutically acceptable formulations comprising an active pharmaceutical ingredient such as androst-5-ene-3.beta., 17.beta.-diol, androst-5-ene- 3.beta.,7.beta., 17.beta.-triol or derivatives of either of these compounds and an air oxidizable excipient that have been stabilized with respect to efficacy. Use of the efficacy-stabilized formulations to treat a number of conditions or symptoms thereof, such as a symptom associated with exposure to radiation is described.
L'invention concerne des formulations pharmaceutiquement acceptables comprenant un principe pharmaceutique actif tel que androst-5-ène-3ß,17ß-diol, androst-5-ène-3ß,7ß,17ß-triol ou des dérivés de l'un quelconque de ces composés et d'un excipient oxydable à l'air et stabilisées quant à leur efficacité. L'utilisation des formulations stabilisées quant à leur efficacité pour traiter un grand nombre d'affections ou symptômes, tels qu'un symptôme associé à l'exposition à un rayonnement, est décrite.
Frincke James M.
Ge Yu
Hu Tao
Liaw Wayne
White Steven K.
Harbor Biosciences Inc.
Sim & Mcburney
LandOfFree
Stabilized therapeutic compositions and formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized therapeutic compositions and formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized therapeutic compositions and formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1786666